112 related articles for article (PubMed ID: 8125834)
1. The entry of meropenem into human macrophages and its immunomodulating activity.
Cuffini AM; Tullio V; Allocco A; Giachino F; Fazari S; Carlone NA
J Antimicrob Chemother; 1993 Nov; 32(5):695-703. PubMed ID: 8125834
[TBL] [Abstract][Full Text] [Related]
2. Interaction of meropenem with humoral and phagocytic defences.
Easmon CS
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():259-64. PubMed ID: 2681125
[TBL] [Abstract][Full Text] [Related]
3. The antibacterial activity of meropenem in combination with gentamicin or vancomycin.
Wise R; Ashby JP; Andrews JM
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():233-8. PubMed ID: 2509417
[TBL] [Abstract][Full Text] [Related]
4. Activity of three {beta}-lactams (ertapenem, meropenem and ampicillin) against intraphagocytic Listeria monocytogenes and Staphylococcus aureus.
Lemaire S; Van Bambeke F; Mingeot-Leclercq MP; Tulkens PM
J Antimicrob Chemother; 2005 Jun; 55(6):897-904. PubMed ID: 15860552
[TBL] [Abstract][Full Text] [Related]
5. Effect of ceftriaxone on the phagocytosis and intracellular killing of Staphylococcus aureus by human macrophages.
Tullio V; Cuffini AM; Cavallo R; Allocco A; Carlone NA
J Chemother; 1994 Jun; 6(3):177-83. PubMed ID: 7983500
[TBL] [Abstract][Full Text] [Related]
6. Meropenem-induced alteration of the susceptibility of Escherichia coli and Staphylococcus aureus to the bactericidal activity of human polymorphonuclear leucocytes.
Herrera-Insúa I; Pérez P; Martínez P; Gómez-Lus ML; Prieto J
J Antimicrob Chemother; 1997 Feb; 39(2):223-8. PubMed ID: 9069543
[TBL] [Abstract][Full Text] [Related]
7. Cellular uptake, and intracellular bactericidal activity of teicoplanin in human macrophages.
Carlone NA; Cuffini AM; Ferrero M; Tullio V; Avetta G
J Antimicrob Chemother; 1989 Jun; 23(6):849-59. PubMed ID: 2527222
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of roxithromycin and erythromycin on cellular immune functions in vitro. 2. Chemotaxis and phagocytosis of 3H-Staphylococcus aureus by human macrophages.
Carlone NA; Cufini AM; Tullio V; Sassella D
Microbios; 1989; 58(234):17-25. PubMed ID: 2739586
[TBL] [Abstract][Full Text] [Related]
9. Activity of meropenem, against gram-positive bacteria.
Kayser FH; Morenzoni G; Strässle A; Hadorn K
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():101-12. PubMed ID: 2808202
[TBL] [Abstract][Full Text] [Related]
10. Comparative pharmacodynamics of meropenem using an in-vitro model to simulate once, twice and three times daily dosing in humans.
Bowker KE; Holt HA; Lewis RJ; Reeves DS; MacGowan AP
J Antimicrob Chemother; 1998 Oct; 42(4):461-7. PubMed ID: 9818744
[TBL] [Abstract][Full Text] [Related]
11. Activity of aztreonam in pneumology, Part 2: Influence on phagocytosis and intracellular killing of human alveolar macrophages.
Velluti G; Garuti GC; Bonucchi ME; Gilioli F; Capelli O; Rovatti E; Covi M
J Chemother; 1994 Feb; 6(1):44-9. PubMed ID: 8071678
[TBL] [Abstract][Full Text] [Related]
12. Rat lung lavage surfactant enhances bacterial phagocytosis and intracellular killing by alveolar macrophages.
O'Neill S; Lesperance E; Klass DJ
Am Rev Respir Dis; 1984 Aug; 130(2):225-30. PubMed ID: 6547813
[TBL] [Abstract][Full Text] [Related]
13. Synergy of ceftazidime and human macrophages on phagocytosis and killing of Staphylococcus aureus and Pseudomonas aeruginosa.
Cuffini AM; Carlone NA; Xerri L; Pizzoglio MF
J Antimicrob Chemother; 1987 Aug; 20(2):261-71. PubMed ID: 3117762
[TBL] [Abstract][Full Text] [Related]
14. Enhanced Staphylococcus aureus susceptibility to immunodefences induced by sub-inhibitory and bactericidal concentrations of imipenem.
Cuffini AM; Tullio V; Allocco A; Fazari S; Giachino F; Carlone NA
J Antimicrob Chemother; 1993 Apr; 31(4):559-68. PubMed ID: 8514650
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial activity of achievable epithelial lining fluid exposures of Amikacin Inhale with or without meropenem.
So W; Crandon JL; Hamada Y; Nicolau DP
J Antimicrob Chemother; 2016 Feb; 71(2):428-37. PubMed ID: 26559690
[TBL] [Abstract][Full Text] [Related]
16. Bactericidal activity of meropenem against Pseudomonas aeruginosa.
Yourassowsky E; Van der Linden MP; Lismont MJ; Crokaert F; Glupczynski Y
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():169-74. PubMed ID: 2509414
[TBL] [Abstract][Full Text] [Related]
17. Bactericidal activity, post antibiotic effect and modified controlled effective regrowth time of meropenem at high concentrations.
Bowker KE; Holt HA; Reeves DS; MacGowan AP
J Antimicrob Chemother; 1996 Dec; 38(6):1055-60. PubMed ID: 9023653
[TBL] [Abstract][Full Text] [Related]
18. Cellular uptake and intracellular bactericidal activity of RP 59500 in murine macrophages.
Desnottes JF; Diallo N
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():107-15. PubMed ID: 1399942
[TBL] [Abstract][Full Text] [Related]
19. Killing kinetics of meropenem against penicillin-resistant pneumococci.
Barakett V; Lesage D; Delisle F; Richard G; Petit JC
J Antimicrob Chemother; 1996 Dec; 38(6):1085-9. PubMed ID: 9023658
[TBL] [Abstract][Full Text] [Related]
20. [Comparative study of intramacrophagic penetration and action on phagocytosis of a macrolide (spiramycin) and a fluoroquinolone (pefloxacin)].
Desnottes JF; Diallo N
Pathol Biol (Paris); 1990 Apr; 38(4):281-5. PubMed ID: 2377388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
